Yehezkel Ben-Ari, founder of Inmed Mediterranean Institute of Neurobiology, receives the 2009 INSERM Grand Prix for his pioneering discoveries in brain maturation, epilepsy, and stroke. He is recognized for his contributions to fundamental, clinical, and therapeutic research.
Researchers at I-STEM Institute have made significant breakthrough in stem cell research by recreating a whole epidermis from human embryonic stem cells. The goal is to provide an unlimited resource of cells as an alternative treatment for victims of third-degree burns and patients with genetic diseases affecting the skin.
French researchers have developed a strategy to promote neuronal regeneration after injury using gene therapy. By blocking the formation of cicatricial tissue, astrocytes can be controlled to promote neuronal survival and trigger axonal growth.
Researchers in France and Germany have successfully produced homogeneous samples of pure and very small fluorescent diamond nanoparticles with high yield. The novel process involves irradiating micron-size diamonds, milling, and purification steps.
Researchers found that vigabatrin reduces taurine levels, leading to retina cell degeneration induced by light. Introducing a taurine-rich diet and reducing light exposure can help curb secondary effects in children treated with the drug.
The European Perinatal Health Report provides comprehensive data on mortality, low birthweight, preterm birth, and other factors affecting pregnancy outcomes. The report highlights significant variations in perinatal health across Europe, with some countries having rates significantly higher than others.
A recent clinical trial has shown remarkable results for patients with obsessive-compulsive disorder (OCD), with 7 out of 10 participants experiencing a substantial reduction in symptoms after deep cerebral stimulation. The treatment, which involves targeting the subthalamic nucleus in the brain, offers a promising alternative to tradi...
Researchers have discovered that the apelin protein can help regulate blood sugar levels in individuals with type II diabetes. Activation of this second pathway improves glucose regulation and offers a potential new treatment option.